Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL460

MOLINDONE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2

Basic Information

ChEMBL ID CHEMBL460
Name MOLINDONE
Phase Approved
Structure Type MOL
InChI Key KLPWJLBORRMFGK-UHFFFAOYSA-N
Therapeutic ✓ Yes

Known Names

Molindona Molindone Spn-810
5
Targets
8
Activities
2
Assay Types
0
PK Parameters
20
Publications
3
Known Names
2
Indications

Molecular Properties

276.4
MW (Da)
1.96
ALogP
3
HBA
1
HBD
45.3
PSA (Ų)
0.92
QED
0
Ro5 Violations
3
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1974
Availability Prescription
Chirality Racemic

Routes of Administration

Oral

Flags

Black Box Warning Natural Product
USAN Year 1967

Extended Properties

Molecular Formula C16H24N2O2
MW 276.38
Aromatic Rings 1
Heavy Atoms 20
NP-Likeness -0.63

Indications

Psychotic Disorders Attention Deficit Disorder with Hyperactivity

ATC Classification

N05AE02
molindone
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOLEPTICS

Activity Summary

Ki 7 meas. best 7.48
Kd 1 meas. best 6.18

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
D(2) dopamine receptor
CHEMBL339
Ki 7.48 7.48 33.1 2
5-hydroxytryptamine receptor 7
CHEMBL3155
Ki 6.58 6.58 265.0 1
Rattus norvegicus
CHEMBL376
Kd 6.18 6.18 660.7 1
5-hydroxytryptamine receptor 2A
CHEMBL322
Ki 5.85 5.85 1412.5 2
D(1A) dopamine receptor
CHEMBL265
Ki 5.8 5.8 1584.9 1

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
22194678 10.1371/journal.pcbi.1002310 Hepatotoxicity 14
15646539 10.1016/s0399-8320(04)95062-2 Unchecked 11
15646539 10.1016/s0399-8320(04)95062-2 NON-PROTEIN TARGET 8
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 2B 3
37468498 10.1038/s41467-023-40064-9 Alpha-1A adrenergic receptor 3
37468498 10.1038/s41467-023-40064-9 Alpha-2A adrenergic receptor 3
37468498 10.1038/s41467-023-40064-9 Progesterone receptor 3
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 2A 3
37468498 10.1038/s41467-023-40064-9 D(1A) dopamine receptor 2
- 10.6019/CHEMBL4651402 SARS-CoV-2 2
37468498 10.1038/s41467-023-40064-9 Gamma-aminobutyric acid receptor subunit alpha-1 2
37468498 10.1038/s41467-023-40064-9 Mu-type opioid receptor 2
6116805 10.1021/jm00141a002 Rattus norvegicus 2
37468498 10.1038/s41467-023-40064-9 Androgen receptor 2
37468498 10.1038/s41467-023-40064-9 Muscarinic acetylcholine receptor M2 2
- 10.1016/S0960-894X(97)00131-5 Dopamine D2 receptor and serotonin 2a receptor 1
12825922 10.1021/jm030030n 5-hydroxytryptamine receptor 7 1
- 10.1016/0960-894X(95)00076-6 Rattus norvegicus 1
- 10.1016/0960-894X(95)00076-6 Dopamine D2 receptor and serotonin 2a receptor 1
38318365 10.1016/j.isci.2024.108907 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 1

Data from ChEMBL 36 via Core Engine